154 related articles for article (PubMed ID: 37553730)
1. Skin fibroblast functional heterogeneity in health and disease.
Bensa T; Tekkela S; Rognoni E
J Pathol; 2023 Aug; 260(5):609-620. PubMed ID: 37553730
[TBL] [Abstract][Full Text] [Related]
2. Dermal Fibroblast Heterogeneity and Its Contribution to the Skin Repair and Regeneration.
Xue M; Zhao R; March L; Jackson C
Adv Wound Care (New Rochelle); 2022 Feb; 11(2):87-107. PubMed ID: 33607934
[No Abstract] [Full Text] [Related]
3. Regeneration of Dermis: Scarring and Cells Involved.
Rippa AL; Kalabusheva EP; Vorotelyak EA
Cells; 2019 Jun; 8(6):. PubMed ID: 31216669
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Pathology: the 2023 Annual Review Issue of The Journal of Pathology.
Jones JL; Poulsom R; Coates PJ
J Pathol; 2023 Aug; 260(5):495-497. PubMed ID: 37580852
[TBL] [Abstract][Full Text] [Related]
5. Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders.
Russo B; Brembilla NC; Chizzolini C
Front Immunol; 2020; 11():648. PubMed ID: 32477322
[No Abstract] [Full Text] [Related]
6. Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases.
Deng CC; Hu YF; Zhu DH; Cheng Q; Gu JJ; Feng QL; Zhang LX; Xu YP; Wang D; Rong Z; Yang B
Nat Commun; 2021 Jun; 12(1):3709. PubMed ID: 34140509
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating Fibrotic Phenotypes of Keloid Dermal Fibroblasts through an Epidermal Growth Factor-Mediated Extracellular Matrix Remodeling.
Kim H; Anggradita LD; Lee SJ; Hur SS; Bae J; Hwang NS; Nam SM; Hwang Y
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672186
[TBL] [Abstract][Full Text] [Related]
8. Understanding the impact of fibroblast heterogeneity on skin fibrosis.
Griffin MF; desJardins-Park HE; Mascharak S; Borrelli MR; Longaker MT
Dis Model Mech; 2020 Jun; 13(6):. PubMed ID: 32541065
[TBL] [Abstract][Full Text] [Related]
9. A developmental basis for the anatomical diversity of dermis in homeostasis and wound repair.
Usansky I; Jaworska P; Asti L; Kenny FN; Hobbs C; Sofra V; Song H; Logan M; Graham A; Shaw TJ
J Pathol; 2021 Mar; 253(3):315-325. PubMed ID: 33197044
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Heterogeneity in Healthy and Wounded Skin.
Ganier C; Rognoni E; Goss G; Lynch M; Watt FM
Cold Spring Harb Perspect Biol; 2022 Jun; 14(6):. PubMed ID: 35667795
[TBL] [Abstract][Full Text] [Related]
12. Toward understanding scarless skin wound healing and pathological scarring.
Karppinen SM; Heljasvaara R; Gullberg D; Tasanen K; Pihlajaniemi T
F1000Res; 2019; 8():. PubMed ID: 31231509
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
14. Skin Cell Heterogeneity in Development, Wound Healing, and Cancer.
Rognoni E; Watt FM
Trends Cell Biol; 2018 Sep; 28(9):709-722. PubMed ID: 29807713
[TBL] [Abstract][Full Text] [Related]
15. Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease.
Shaw TJ; Rognoni E
Curr Rheumatol Rep; 2020 Jun; 22(8):33. PubMed ID: 32562113
[TBL] [Abstract][Full Text] [Related]
16. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
Marty P; Chatelain B; Lihoreau T; Tissot M; Dirand Z; Humbert P; Senez C; Secomandi E; Isidoro C; Rolin G
Biomed Pharmacother; 2021 Mar; 135():111182. PubMed ID: 33433355
[TBL] [Abstract][Full Text] [Related]
17. An updated review of the immunological mechanisms of keloid scars.
Lee CC; Tsai CH; Chen CH; Yeh YC; Chung WH; Chen CB
Front Immunol; 2023; 14():1117630. PubMed ID: 37033989
[TBL] [Abstract][Full Text] [Related]
18. Molecular dissection of abnormal wound healing processes resulting in keloid disease.
Shih B; Garside E; McGrouther DA; Bayat A
Wound Repair Regen; 2010; 18(2):139-53. PubMed ID: 20002895
[TBL] [Abstract][Full Text] [Related]
19. Fussel-15, a new player in wound healing, is deregulated in keloid and localized scleroderma.
Arndt S; Schmidt J; Wacker E; Karrer S; Bosserhoff AK
Am J Pathol; 2011 Jun; 178(6):2622-31. PubMed ID: 21641385
[TBL] [Abstract][Full Text] [Related]
20. 3D modeling of keloid scars in vitro by cell and tissue engineering.
Suttho D; Mankhetkorn S; Binda D; Pazart L; Humbert P; Rolin G
Arch Dermatol Res; 2017 Jan; 309(1):55-62. PubMed ID: 27942931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
